CAR-T cell therapy CART-ASCT-CART2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CAR-T cell therapy CART-ASCT-CART2, covering 2025-08-04 to 2025-08-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study of VRd-based Regimen Combined With CART-ASCT-CART2 Treatment in NDMM Patients With P53 Abnormalities [Phase 2]